Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We report a newly emerged SARS-CoV-2 Omicron subvariant FY.4 that has mutations Y451H in spike and P42L in open reading frame 3a proteins. FY.4 emergence coincided with increased SARS-CoV-2 cases in coastal Kenya during April-May 2023. Continued SARS-CoV-2 genomic surveillance is needed to identify new lineages to inform COVID-19 outbreak prevention.

Original publication

DOI

10.3201/eid2911.230894

Type

Journal article

Journal

Emerg Infect Dis

Publication Date

11/2023

Volume

29

Pages

2376 - 2379

Keywords

COVID-19, FY.4, Kenya, Kilifi, Omicron, SARS, SARS-CoV-2, coronavirus, coronavirus disease, respiratory infections, severe acute respiratory syndrome coronavirus 2, viruses, zoonoses, Humans, COVID-19, Kenya, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Mutation